The Bcl-2 family has been reported to play a crucial role in the chemoresistance of ovarian cancer, and the molecules target Bcl-2 have shown efficacy in overcoming the chemoresistance of ovarian cancer [117]. This evidence concerns the gene BCL2 and ovarian cancer.